NCT05916755
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Vall d'Hebron Institute of Oncology Barcelona, Spain
Clinical trial condition
Breast Neoplasms
Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.
609 public trials
216 recruiting studies
Breast Neoplasms trial results
NCT05447702
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- West China Hospital, Sichuan University Chengdu, Sichuan, China
Recruiting
A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After NAC in TNBC
NCT04501523
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Sunyat-sen Memorial Hospital Guandong, Guangdong, China
NCT05037825
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +37 more
- Locations
-
- Baptist Health Clinical Research Elizabethtown, Kentucky, United States
NCT04481763
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Chunling Jiang Nanchang, Jiangxi, China
NCT04437160
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
- Locations
-
- Cancer Hospital & Institute Chinese Academy of Medical Sciences (CAMS) Beijing, Beijing Municipality, China
Enrolling by Invitation
Patient Centered Clinical Decision Support for Hereditary Cancer Syndromes
NCT06914726
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +37 more
- Locations
-
- HealthPartners Medical Group Minneapolis, Minnesota, United States
Enrolling by Invitation
A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
NCT07218003
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +54 more
- Locations
-
- UCSF Medical Center San Francisco, California, United States
- Yale Cancer Center New Haven, Connecticut, United States
- START Midwest Grand Rapids, Michigan, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Enrolling by Invitation
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
NCT06885424
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +67 more
- Locations
-
- Banner Health Gilbert, Arizona, United States
- Mayo Clinic Rochester, Minnesota, United States
- NYU Langone Medical Center New York, United States
Enrolling by Invitation
Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study
NCT06843681
- Conditions
- Breast Carcinoma In Situ, Breast Carcinoma in Situ, Breast Diseases, +9 more
- Locations
-
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China